![Jacobo Cruces Colado](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Jacobo Cruces Colado
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
GalChimia SA
![]() GalChimia SA Chemicals: SpecialtyProcess Industries GalChimia SA engages in the manufacture and commercialization of chemical products including pharmaceutical substances, chemical reagents, pesticide additives and synthetic industrial acids. The firm also offers custom synthesis, contract research, process development and reaction optimization services. The company was founded by Carme Pampin, Gabriel Tojo, Pampin Casal Maria Do Carme and Jacobo Cruces in 2001 and is headquartered in A Coruna, Spain.
5
| Private Company | Chemicals: Specialty | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jacobo Cruces Colado tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Santiago de Compostela | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | Biotechnology | Founder |
Statistiche
Distribuzione geografica
Spagna | 3 |
Settori
Consumer Services | 2 |
Health Technology | 2 |
Posizioni
Doctorate Degree | 3 |
Founder | 2 |
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Contatti più connessi
- Borsa valori
- Insiders
- Jacobo Cruces Colado
- Connessioni Società